|
|
Reference
|
|
  
|
Agewall, S. (2006) Matrix metalloproteinases and cardiovascular disease. European heart journal, 27(2): 121-2
|
|
|
Agewall, S., Henareh, L., Kublickiene, K. (2006) Endothelial function in conduit and resistance arteries in men with coronary disease. Atherosclerosis, 184(1): 130-6
|
|
|
Ardans, J.A., Blum, A., Mangan, P.R., Wientroub, S., Cannon, R.O., Wahl, L.M. (2001) Raloxifene-mediated increase in matrix metalloproteinase-1 production by activated monocytes. Arteriosclerosis, thrombosis, and vascular biology, 21(8): 1265-8
|
|
|
Blankenberg, S., Rupprecht, H.J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., Tiret, L. (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation, 107(12): 1579-85
|
|
|
Brown, D.L., Hibbs, M.S., Kearney, M., Loushin, C., Isner, J.M. (1995) Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina. Circulation, 91(8): 2125-31
|
|
|
Cleutjens, J.P., Kandala, J.C., Guarda, E., Guntaka, R.V., Weber, K.T. (1995) Regulation of collagen degradation in the rat myocardium after infarction. Journal of molecular and cellular cardiology, 27(6): 1281-92
|
|
 4
|
Galis, Z.S., Sukhova, G.K., Lark, M.W., Libby, P. (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest, 94(6): 2493-503
|
|
|
Hansson, G.K. (2009) Atherosclerosis-an immune disease: The Anitschkov lecture 2007. Atherosclerosis, 202(1), str. 2-10
|
|
1
|
Hansson, G.K., Libby, P. (2006) The immune response in atherosclerosis: a double-edged sword. Nature reviews. Immunology, 6(7): 508-19
|
|
|
Hirohata, S., Kusachi, S., Murakami, M., Murakami, T., Sano, I., Watanabe, T., Komatsubara, I., Kondo, J., Tsuji, T. (1997) Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction. Heart (British Cardiac Society), 78(3): 278-84
|
|
|
Inokubo, Y., Hanada, H., Ishizaka, H., Fukushi, T., Kamada, T., Okumura, K. (2001) Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. American heart journal, 141(2): 211-7
|
|
|
Jude, B., Agraou, B., McFadden, E.P., Susen, S., Bauters, C., Lepelley, P., Vanhaesbroucke, C., Devos, P., Cosson, A., Asseman, P. (1994) Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina. Circulation, 90(4): 1662-8
|
|
|
Kai, H., Ikeda, H., Yasukawa, H., Kai, M., Seki, Y., Kuwahara, F., Ueno, T., Sugi, K., Imaizumi, T. (1998) Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. Journal of the American College of Cardiology, 32(2): 368-72
|
|
|
Kleiner, D.E., Stetler-Stevenson, W.G. (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Analytical biochemistry, 218(2): 325-9
|
|
|
Leone, A. (2003) Relationship between cigarette smoking and other coronary risk factors in atherosclerosis: risk of cardiovascular disease and preventive measures. Current pharmaceutical design, 9(29): 2417-23
|
|
|
Nagase, H., Woessner, J.F. (1999) Matrix metalloproteinases. J Biol Chem, 274: 21491-4
|
|
|
Ravn, H.B., Falk, E. (1999) Histopathology of plaque rupture. Cardiology clinics, 17(2): 263-70, vii
|
|
|
Sasaguri, Y., Murahashi, N., Sugama, K., Kato, S., Hiraoka, K., Satoh, T., Isomoto, H., Morimatsu, M. (1994) Development-related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Laboratory investigation, 71(2): 261-9
|
|
|
Shah, P.K. (1998) Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vascular medicine (London, England), 3(3): 199-206
|
|
|
|
|